About Us

Creative Biolabs is a leading service provider of drug discovery & development with great dedication to accelerating non-alcoholic steatohepatitis (NASH) drug development. With more than 10 years of experience in antibody engineering and drug development, we can be the most reliable and qualified contract manufacturer for your NASH research project. Regardless of the stage, scope or scale of your project, we can provide you with customized solutions and high-quality services for NASH's early overcoming.

About Our Company

Creative Biolabs, Inc. is a New York-based company with more than 10 years of experience in the field of biology and pharmaceuticals. Through continuous accumulation, exploration and expansion, we have the ability to promote change and help people accelerate the fighting against NASH. Data show that the overall prevalence of NASH among American adults is about 12%. NASH is expected to become a major cause of liver transplantation in the United States by 2020. But up to now, there is still no approved drug for NASH therapy. Creative Biolabs has set up a professional doctoral research team. They have rich expertise and experience in NASH and other related diseases. They are committed to helping the global biomedical research community to solve the challenges of NASH diseases.

About Our Service

Creative Biolabs has been providing innovative life science solutions and building trustworthy partnerships for more than 10 years. Based on advanced drug discovery and antibody engineering platform, we have established a path supported by drug discovery, with a large pool of proprietary molecules, advanced research and development facilities, and can provide comprehensive services for NASH research and treatment. In target development, we provide a broad combination of laboratory and manufacturing services for NASH therapy, including nuclear transcription factor development, lipotoxicity development, oxidative stress development, inflammation development, fibrosis development, strategy design and so on. In addition, we also provide the development services of NASH diagnostic biomarkers and NASH preclinical models.

Features of Our Services

• Technical support for small molecule target discovery and development
• A full range of services that can be customized to meet customer' requirements
• Dedicated R&D and manufacturing teams
• Robust and mature quality system
• Contract R&D, process development and manufacturing services

With these technologies and expertise, we are confident to help researchers get success in early-stage projects and better contribute to NASH treatment. If you are interested in any of our services, please feel free to contact us.